(Q41104937)

26 September 2017

1 reference

title

Inhaled sodium cromoglycate (English)

1 reference

26 September 2017

1

Holgate ST

1 reference

26 September 2017

publication date

1 August 1996

1 reference

26 September 2017

1 reference

26 September 2017

volume

90

1 reference

26 September 2017

issue

7

1 reference

26 September 2017

page(s)

387-390

1 reference

Sodium cromoglycate (Intal) as an anti-inflammatory agent for the treatment of chronic asthma

26 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990110-9

7 January 2021

A double-blind trial of disodium cromoglycate in the treatment of allergic bronchial asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990110-9

7 January 2021

Long-term trial of disodium cromoglycate and isoprenaline in children with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990110-9

7 January 2021

A controlled study of cromolyn sodium sponsored by the Drug Committee of the American Academy of Allergy

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990110-9

7 January 2021

Disodium cromoglycate (intal) in the treatment of bronchial asthma in children

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990110-9

7 January 2021

Cromolyn in extrinsic and intrinsic asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990110-9

7 January 2021

How much aerosol reaches the lungs of wheezy infants and toddlers?

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990110-9

7 January 2021

Delivery of therapeutic aerosols to intubated babies

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990110-9

7 January 2021

Dose-response effect of sodium cromoglycate pressurised aerosol in exercise induced asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990110-9

7 January 2021

Sodium cromoglycate as a pressurised aerosol (vicrom) in exercise-induced asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990110-9

7 January 2021

Airway responses to hyperventilation of cold dry air: duration of protection by cromolyn sodium

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990110-9

7 January 2021

Double-blind comparison of the protective effect of sodium cromoglycate and ketotifen on exercise-induced asthma in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990110-9

7 January 2021

Inhibition of exercise-induced-asthma (EIA) by nedocromil sodium and sodium cromoglycate in children

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990110-9

7 January 2021

Comparison of the protective effects of cromolyn sodium and nedocromil sodium in the treatment of exercise-induced asthma in children

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990110-9

7 January 2021

Comparative effects of inhaled salbutamol, sodium cromoglycate, and beclomethasone dipropionate on allergen-induced early asthmatic responses, late asthmatic responses, and increased bronchial responsiveness to histamine

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990110-9

7 January 2021

Theophylline does not inhibit allergen-induced increase in airway responsiveness to methacholine.

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990110-9

7 January 2021

Inhaled sodium cromoglycate in angiotensin-converting enzyme inhibitor cough

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990110-9

7 January 2021

Bronchospasm induced by inhalation of substance P: effect of sodium cromoglycate

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990110-9

7 January 2021

Bradykinin-induced bronchoconstriction: inhibition by nedocromil sodium and sodium cromoglycate

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990110-9

7 January 2021

Inhaled sodium metabisulphite induced bronchoconstriction: inhibition by nedocromil sodium and sodium cromoglycate

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990110-9

7 January 2021

Comparison of 1 mg and 5 mg sodium cromoglycate metered dose inhalers in the treatment of asthma: a 12-week double-blind, parallel group trial

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990110-9

7 January 2021

Comparison between sodium cromoglycate (MDI: metered-dose inhaler) and beclomethasone dipropionate (MDI) in treatment of adult patients with mild to moderate bronchial asthma. A double-blind, double-dummy randomized, parallel-group study

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990110-9

7 January 2021

Nedocromil sodium and sodium cromoglycate in patients aged over 50 years with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990110-9

7 January 2021

Long-Term Treatment with Sodium Cromoglycate, Nedocromil Sodium and Beclomethasone Dipropionate Reduces Bronchial Hyperresponsiveness in Asthmatic Subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990110-9

7 January 2021

The effect of sodium cromoglycate on upper and lower respiratory symptoms in children born prematurely

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990110-9

7 January 2021

The place of cromolyn sodium in the long-term management of childhood asthma based on a 3- to 5-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990110-9

7 January 2021

10.1016/S0954-6111(96)90110-9

Identifiers

DOI

1 reference

26 September 2017

1 reference